Ameritas Investment Partners, Inc. Amylyx Pharmaceuticals, Inc. Transaction History

Ameritas Investment Partners, Inc.

  • $2.84 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$18.08 - $23.45 $18,278 - $23,707
1,011 Added 25.06%
5,046 $92,000
Q4 2022

Feb 13, 2023
BUY
$29.75 - $39.26 $37,812 - $49,899
1,271 Added 45.98%
4,035 $149,000
Q3 2022

Nov 14, 2022
BUY
$17.15 - $30.92 $34,643 - $62,458
2,020 Added 271.51%
2,764 $77,000
Q1 2022

May 13, 2022
BUY
$12.85 - $32.9 $9,560 - $24,477
744 New
744 $10,000

Others Institutions Holding AMLX

# of Institutions
139
Shares Held
46.5M
Call Options Held
226K
Put Options Held
909K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email